You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDKN2A

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Head Neck Cancer, Advanced Cancer, Metastatic Cancer Trial in Bordeaux, Lyon, Nice (Abemaciclib)

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Bordeaux, France
  • +2 more
Jul 22, 2022

HPV-unrelated Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (Palbociclib, Cetuximab)

Recruiting
  • HPV-unrelated Head and Neck Squamous Cell Carcinoma
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 7, 2022

GBM, Glioblastoma, Brain Tumor Trial in Dallas (Abemaciclib, Bevacizumab)

Active, not recruiting
  • GBM
  • +3 more
  • Dallas, Texas
    UT Southwestern Medical Center
Jan 23, 2022

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

CDKN2A-p16 Positive, Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage I Oropharyngeal Squamous Cell

Recruiting
  • CDKN2A-p16 Positive
  • +5 more
  • Tucson, Arizona
    The University of Arizona Medical Center-University Campus
Mar 7, 2022

Breast Cancer Trial (GSK3326595)

Completed
  • Breast Cancer
  • London, Ontario, Canada
    St. Joseph's Health Care London
Oct 24, 2022

Gastric Cancer, Healthy Trial in Hangzhou (No intervention)

Recruiting
  • Gastric Cancer
  • Healthy
  • No intervention
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Aug 7, 2023

Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

Recruiting
  • Neurofibromatosis 1
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Germline Mutations Associated With Hereditary Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Invitae Multi-Cancer Panel ®
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Mar 22, 2022

Clinical, Laboratory, and Epidemiologic Characterization of

Recruiting
  • Melanoma
  • Dysplastic Nevus Syndrome
    • Bethesda, Maryland
    • +1 more
    Jan 18, 2023

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Edmonton, Alberta, Canada
    • +9 more
    Jan 9, 2023

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

    Recruiting
    • Pancreatic Cancer
    • +3 more
    • Bio-specimen Collection: Blood
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 21, 2023

    Dalpiciclib Combined With Third-generation EGFR-TKI in EGFR

    Not yet recruiting
    • Non-small Cell Lung Cancer Confirmed by Histopathology or Cytology
    • +6 more
      • (no location specified)
      Aug 9, 2022

      Metastatic Malignant Tumor, Solid Tumor, Unresectable Malignant Tumor Trial in Chicago (Ilorasertib, Laboratory Biomarker

      Completed
      • Metastatic Malignant Neoplasm
      • +2 more
      • Chicago, Illinois
        University of Chicago Comprehensive Cancer Center
      Apr 18, 2019

      Cancer, Solid Tumor, Thromboembolism Trial in Tripoli (Palbociclib, Rivaroxaban, SNP)

      Recruiting
      • Cancer
      • +12 more
      • Tripoli, North Lebanon, Lebanon
      • +1 more
      Oct 5, 2023

      Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in United States (Crizotinib, Palbociclib, Sunitinib)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • +2 more
      • Birmingham, Alabama
      • +125 more
      Nov 21, 2022

      Pancreas Cancer, Exosomes, Extracellular Vesicles Trial

      Not yet recruiting
      • Pancreas Cancer
      • +3 more
        • (no location specified)
        Dec 6, 2022

        Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation Trial in United States (drug, diagnostic test, other)

        Recruiting
        • Pancreas Cancer
        • +4 more
        • New Haven, Connecticut
        • +7 more
        Dec 12, 2022

        Pancreatic Cyst, Molecular, Chemical Analysis of Cystic Fluid Trial in Seoul

        Recruiting
        • Pancreatic Cyst
        • Molecular, Chemical Analysis of Cystic Fluid
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Aug 10, 2022

          Solid Tumor Trial in United States (IDE397, Docetaxel, Paclitaxel)

          Recruiting
          • Solid Tumor
          • Scottsdale, Arizona
          • +10 more
          Jul 20, 2022

          Chordoma Trial in Essen, Heidelberg, Ulm (Palbociclib)

          Recruiting
          • Chordoma
          • Essen, Germany
          • +2 more
          Dec 6, 2021

          Arrhythmogenic Cardiomyopathy, PKP2-ACM, PKP2-ARVC Trial (LX2020)

          Not yet recruiting
          • Arrhythmogenic Cardiomyopathy
          • +2 more
          • LX2020
          • (no location specified)
          Oct 25, 2023

          CYP1A2, ABCB1, CYP2C9 and Plasma Concentration of Agomelatine in

          Not yet recruiting
          • Polymorphism, Genetic
          • +5 more
            • (no location specified)
            Nov 3, 2023

            Blood Metabolic Markers in Type 2 Diabetes Mellitus of Different

            Not yet recruiting
            • Diabetes Mellitus, Type 2
            • No intervention
            • Jinan, Shandong, China
              Peng Wu
            Nov 24, 2023